Genpact ran CMC lifecycle regulatory support for a major pharma to free staff and speed submissions.
The client wanted to cut costs while balancing new product development with lifecycle management. Genpact Regulatory Affairs supplied CMC lifecycle management support, ancillary documentation, tender support and certificates of pharmaceutical products. The page says submissions sped up, tender win rates rose and staff freed up, and cites 20-30% efficiency in stage one.
Genpact is a global professional services firm, used by pharma for pharmacovigilance AI, regulatory affairs support, compliance and intelligent operations
This sits in the Scale & Govern stage of the AI use-case lifecycle: Named examples from the tools pharma teams use to monitor, govern and keep validating an AI system once it is already live in production.
Published by Genpact on its own site — read the original case study on genpact.com ↗
Note: Mostly a services offering page; AI role is not detailed.
Related use cases
- 01A consumer health company used Genpact's generative AI to cut regulatory intelligence reporting from weeks to hours.
- 02Bayer adopted Genpact's PVAI suite to automate adverse event extraction and case management.
- 03How (And Why) AdeptID Achieved EU AI Act Compliance for Talent Matching
- 04Establishing Lifecycle AI Risk Management for Defense Operations
- 05Unifying AI Governance Across Global Operations at Scale
- 06Embedding & Automating AI Governance in Enterprise Workflows